Home » Newsletters » BioWorld

BioWorld

Jan. 15, 1992

View Archived Issues

CANADA APPROVE IMMUNOMEDICS TRIALS

ROBERTS TO BUY TRIALS MANAGEMENT COMPANY

CYTRX FILES IND FOR BURN TREATMENT

ONCOSCINT APPROVED IN ITALY

ELAN AGREES TO ACQUIRE VEGA

ALPHA-BETA BEGINS FIRST TRIALS

ENZO STOCK CONTINUES TO RISE

ZYNAXIS FILES FOR 2 MILLION-SHARE IP0

START-UP FOCUSES ON TRANSCRIPTION FACTORS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...